Modified PKA Substrate


Catalog Number Pack Size List Price* Quantity
C01-58B 1 mg 150,00 Add

* CHF, excl. 8.1% VAT and shipping costs


Product Description

Peptide Substrates
The modified PKA Substrate peptide sequence (modified-CGRTGRRNSI-amide) is based on the cAMP-dependent protein kinase inhibitor alpha (amino acid 15-23).

Category Peptide
Supplier SignalChem
Application KA
Regulatory Status RUO
Research Field Apoptosis/Autophagy, Cardiovascular Disease, ERK/MAPK Pathway, Inflammation, Invasion/Metastasis, Metabolic Disorder, Neurobiology, NfkB Pathway, PKA/PKC Pathway, Ser/Thr Kinases
Format 1mg of modified peptide was supplied in 1ml of H2O.
Tech. Data Sheet View datasheet
Link To Supplier http://www.signalchem.com
Shipping Details -20°C
Material Safety Data Sheet Download PDF